![](/img/cover-not-exists.png)
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients
Jean-Yves Pierga, Suzette Delaloge, Marc Espié, Etienne Brain, Brigitte Sigal-Zafrani, Marie-Christine Mathieu, Philippe Bertheau, Jean Marc Guinebretière, Marc Spielmann, Alexia Savignoni, Michel MarVolume:
122
Language:
english
Pages:
9
DOI:
10.1007/s10549-010-0939-3
Date:
July, 2010
File:
PDF, 236 KB
english, 2010